Filing Details
- Accession Number:
- 0001140361-17-037214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-02 21:07:08
- Reporting Period:
- 2017-09-28
- Accepted Time:
- 2017-10-02 21:07:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1274826 | Robert Baffi | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-28 | 15,500 | $92.50 | 129,083 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-28 | 2,915 | $92.06 | 28,761 | No | 4 | S | Indirect | Shares held by Baffi Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | Shares held by Baffi Family Trust |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.
- The price in column 4 is the weighted average price. The price actually received ranged from $91.92 to $92.90. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- All shares sold at the same price.